Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Farrell, Hayden J.a | Andrews, Sophie C.a | Ryan, Nicholas P.b; c | Davis, Marie-Claireb | Gordon, Stephaniea | Stout, Julie C.a | Fisher, Fionab; *
Affiliations: [a] School of Psychological Sciences, and, Institute of Cognitive and Clinical Neurosciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia | [b] Calvary Health Care Bethlehem, Statewide Progressive Neurological Disease Service, Caulfield South, VIC, Australia | [c] Cognitive Neuroscience Unit, School of Psychology, Deakin University, Geelong, VIC, Australia
Correspondence: [*] Correspondence to: Dr. Fiona Fisher, Calvary Health Care Bethlehem, Caulfield South, Victoria 3162, Australia. Tel.: +61 3 03 9595 3255; E-mail: [email protected].
Abstract: Background:DriveSafe DriveAware (DSDA) has been validated as an off-road screening tool for predicting on-road driving performance in clinical populations, but its utility in people with Huntington’s disease (HD) is unknown. Objective:Our aim was to evaluate the utility of DSDA in people with HD by demonstrating sensitivity of DSDA scores to HD progression and exploring associations between DSDA performance and cognitive functions that are essential to driving and impaired in people with HD. Methods:We administered the iPad application version of DSDA to 26 pre-symptomatic and symptomatic participants with HD. Disease progression was assessed via measures of motor impairment, disease burden and functional capacity. Standardised neuropsychological tests were used to assess cognitive function across several domains including attention, processing speed, planning, and visuoperception. Results:Results underscore the sensitivity of DSDA to HD progression and cognitive impairment; that is, poorer DSDA performance was associated with greater HD severity and poorer cognitive ability across the domains of attention, processing speed, and planning. Nevertheless, we identified a proportion of participants with HD who were predicted to pass on-road testing based on DSDA, but scored in the impaired range on multiple cognitive tests. These participants tended to score closer to the cut-off score used by DSDA to categorise pass/fail outcomes. Conclusions:Our findings demonstrate potential for use of DSDA in the HD population, however, significant variability in cognitive performance among those predicted to ‘pass’ on-road driving assessment suggests the screening tool requires further development for use with HD drivers.
Keywords: Huntington’s disease, automobile driving, disease progression, cognitive dysfunction
DOI: 10.3233/JHD-180323
Journal: Journal of Huntington's Disease, vol. 8, no. 1, pp. 87-95, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]